ORIC SCHEDULE 13G/A: SEC filing

Viking Global Investors LP and affiliated entities

Filed with the SEC on · accession 0000905148-26-004951

ORIC filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -4.3% by the first close after the filing.

Summary of the filing

Viking Global Investors LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 6,002,989 shares (5.7%) of Oric Pharmaceuticals common stock, including shares underlying pre-funded warrants, as of September 30, 2026.

Key details

Shares beneficially owned by Viking Global Investors LP$6.0M
Shares directly owned by Viking Global Opportunities Illiquid Investments Sub-Master LP$2.3M
Shares directly owned by Viking Global Opportunities Drawdown (Aggregator) LP$1.2M
Shares underlying warrants held by Viking Global Opportunities Illiquid Investments Sub-Master LP$1.4M
Shares underlying warrants held by Viking Global Opportunities Drawdown (Aggregator) LP$1.0M
Reporting person / beneficial ownerViking Global Investors LP
Reporting person / beneficial ownerViking Global Opportunities Parent GP LLC
Reporting person / beneficial ownerViking Global Opportunities GP LLC
Reporting person / beneficial ownerViking Global Opportunities Portfolio GP LLC
Reporting person / direct holderViking Global Opportunities Illiquid Investments Sub-Master LP
Reporting person / beneficial ownerViking Global Opportunities Drawdown GP LLC
Reporting person / beneficial ownerViking Global Opportunities Drawdown Portfolio GP LLC
Reporting person / direct holderViking Global Opportunities Drawdown (Aggregator) LP
Subject companyOric Pharmaceuticals, Inc.
Reporting person / individualO. Andreas Halvorsen
Reporting person / individualRose S. Shabet

How ORIC stock reacted

Close before

$7.86

Nov 13, 2026

First close after

-4.33%

$7.52

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ORIC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ORIC?

Click here

Frequently asked questions

What did ORIC file with the SEC on Nov 16, 2026?

ORIC filed a SCHEDULE 13G/A (SEC filing). Viking Global Investors LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 6,002,989 shares (5.7%) of Oric Pharmaceuticals common stock, including shares underlying pre-funded warrants, as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ORIC stock react to this filing?

ORIC closed at $7.86 before the filing and $7.52 on Nov 16, 2026 (-4.33%).

Other ORIC SEC filings

Get alerts when ORIC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days